Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2012; 18(7): 589-600
Published online Feb 21, 2012. doi: 10.3748/wjg.v18.i7.589
Published online Feb 21, 2012. doi: 10.3748/wjg.v18.i7.589
Scientific name | Part | Type of study | Model | Concomitant drugs | Duration of study | Results | Ref. |
Aloe vera | Gel | Placebo-controlled double-blind trial | IBS patients | - | 1 mo | No difference between treatment and placebo groups in response to treatment at 1 mo diarrhea-predominant patients showed a trend towards a response to treatment at 1 mo | [17] |
Curcuma longa | Rhizome | Partially blinded, randomized, two-dose, pilot study | IBS patients | - | 8 wk | ↓Abdominal pain/discomfort score Significant improvements in IBS QOL scales Approximately two thirds of all subjects reported an improvement in symptoms after treatment | [18] |
Curcuma xanthorrhiza | Rhizome | Randomized, double-blind, placebo-controlled trial | IBS patients | - | 18 wk | ↑IBS-related pain ↓IBS-related distension but more decrease was seen in placebo The global assessment of changes in IBS symptoms and psychological stress due to IBS did not differ significantly among groups | [19] |
Cynara scolymus | Aqueous-alcohol extract of leaf | Postmarketing surveillance study | IBS patients | - | 6 wk | ↓Severity of symptoms reported by both physicians and patients 96% of patients rated this drug as better than or at least equal to previous therapies Very good tolerability | [24] |
Aqueous extract of leaf | Dose-ranging, open, postal study | IBS patients | - | 2 mo | ↓IBS incidence by 26.4% A significant shift in self-reported usual bowel pattern away from “alternating constipation/diarrhea” toward “normal”↓NDI total symptom score by 41% 20% improvement in the NDI total QOL score | [23] | |
Fumaria officinalis | Whole plant | Randomized, double-blind, placebo-controlled trial | IBS patients | - | 18 wk | ↓IBS-related pain ↑IBS-related distension The global assessment of changes in IBS symptoms and psychological stress due to IBS did not differ significantly among group | [19] |
Hypericum perforatum | Aerial parts | Randomized, double-blind, placebo-controlled trial | IBS patients | - | 12 wk | ↓Overall BSS in both groups with the placebo arm having significantly lower scores at 12 wk compared with Hypericum group A similar proportion of subjects in each treatment group believed that the study drug they received decreased IBS life interferences | [28] |
Open-label, uncontrolled trial | IBS women | - | 8 wk | ↓autonomic nervous system to different stressor Improvement of Gastrointestinal symptoms of IBS | [29] | ||
Iberis amara | Whole plant extract | Double-blind, randomized, placebo-controlled, multi-centre trial | IBS patients | - | 4 wk | Significant improvement in IBS symptom scale and abdominal pain scale in Iberis group compared with placebo | [44] |
Maranta arundinacea | Root | Uncontrolled | Diarrhea predominant- IBS patients | - | 1 mo | ↓Diarrhoea ↓Abdominal pain | [30] |
Menthe piperita | Essence | Prospective double blind placebo-controlled randomized trial | IBS patients | - | 4 wk | 75% of the patients in the treatment group showed a > 50% reduction of basal total IBS symptoms score compared with 38% in the placebo group (P < 0.009) a statistically significant reduction of the total IBS symptoms score in treatment group compared with T (0), while no change was found with the placebo | [34] |
Randomized double-blind placebo-controlled study | IBS patients | - | 8 wk | The number of subjects free from abdominal pain or discomfort changed from 0 at wk 0 to 14 at wk 8 in the treatment group and from 0 to 6 in controls (P < 0.001). ↓Severity of abdominal pain significantly in the drug group as compared to controls Improvement in the QOL in the treatment group There was no significant adverse reaction | [33] | ||
Randomized, double-blind controlled trial | IBS patients | - | 2 wk | 76% of the patients receiving peppermint oil reported changes in the severity of symptom scale at the end of trial compared with 19% receiving placebo | [35] | ||
Improvements in the change of symptom scale in 71% of the patients receiving peppermint oil compared with 43% receiving placebo | |||||||
No significant differences between groups in the Gastrointestinal Symptom Rating Scale | |||||||
No changes in symptoms such as abdominal rumbling, abdominal distention, belching, gas, and heartburn in treatment group compared with placebo | |||||||
Mean severity of pain symptoms in the treatment group was significantly lower than that in the placebo | |||||||
IBS patients | - | 1 mo | Significant reduction in the abdominal pain, abdominal distension, stool frequency, borborygmi, flatulence in the treatment group compared to placebo | [32] | |||
Symptom improvements after essence therapy were significantly better than after placebo | |||||||
No significant changes in liver function test results. | |||||||
Paeonia lactiflora | Paeoniflorin; Active principle of root | In vivo | Neonatal maternal separation-induced visceral hyperalgesia in rats | - | Single dose | A dose-dependent analgesic effect Blockage of analgesic effect of Paeoniflorin by nor-binaltorphimine, dl-α-methyltyrosine, and yohimbine. Analgesic effect may be mediated by kappa-opioid receptors and α(2)-adrenoceptors in the central nervous system | [39] |
Plantago psyllium | Seed | Randomized placebo controlled trial | IBs patients | - | 12 wk | Significantly greater proportion of responders in the psyllium group than in the placebo group | [40] |
↓Symptom severity significantly in the psyllium group compared with the placebo | |||||||
No differences in QOL |
Name of preparation | Composition (part) | Type of study | Model | Concomitant drugs | Duration of study | Results | Ref. |
Carmint | Mentha piperita (leaf) | Double-blind, randomized, placebo-controlled, multicenter clinical trial | IBS patients | Loperamide or psyllium (based on their predominant bowel function) | 8 wk | Severity and frequency of abdominal pain/discomfort were significantly lower in the Carmint group than the placebo group | [41] |
Melissa officinalis (leaf) | |||||||
Coriandrum sativum (fruit) | |||||||
CHM | Codonopsis pilosulae (root) | Randomized, double-blind, placebo-controlled trial | IBS patients | - | 16 wk | Significant improvement in bowel symptom scores as rated by patients and by gastroenterologists | [42] |
Agastaches seu pogostemi (whole plant) | Significant global improvement as rated by patients and by gastroenterologists | ||||||
Ledebouriella sesloidis (root) | Patients reported that treatment significantly ↓ the degree of interference with life caused by IBS symptoms | ||||||
Coicis lachryma-jobi (seed) | |||||||
Bupleurum chinensis (whole plant) | |||||||
Artemisia capillaries (whole plant) | |||||||
Atractylodis macrocephalae (rhizome) | |||||||
Magnolia officinalis (bark) | |||||||
Citrus reticulata (pericarp) | |||||||
Zingiber officinale (rhizome) | |||||||
Fraxinus spp. (bark) | |||||||
Poria cocos (sclerotium) | |||||||
Angelica dahurica (root) | |||||||
Plantago spp. (seed) | |||||||
Phellodendron spp. (bark) | |||||||
Glycyrrhiza uralensis (root) | |||||||
Paeonia lactiflora (root) | |||||||
Saussurea lappa (root) | |||||||
Coptidis spp. (rhizome) | |||||||
Schisandra spp. (fruit) | |||||||
C-IBS formula | Lactulose Ulmus fulva (bark) Glycyrrhiza glabra (root) Avena sativa (bran) | A two arm, open-label, uncontrolled pilot study | Constipation-predominant IBS | - | 2 wk | A 20% increase in bowel movement frequency ↓ in straining, abdominal pain, bloating, and global IBS symptom severity improvements in stool consistency well-tolerated | [54] |
DA-IBS formula | Vaccinium myrtillus (fruit) | A two arm, open-label, uncontrolled pilot study | Diarrhea-predominant and alternating bowel | - | 2 wk | a small, but significant increase in bowel movement frequency | [54] |
Ulmus fulva (bark) Cinnamomum zeylanicum (bark) | habit IBS patients | ↓ in straining, abdominal pain, bloating, flatulence, and global IBS symptoms well-tolerated | |||||
Agrimonia eupatoria (aerial part) | - | ||||||
Iberogast (STW 5) | Iberis amara (whole plant) | In vitro | Human intestinal mucosa/submucosa preparations | A dose-dependent increase in ion secretion in human tissue and T84 cells evoke an increased spike discharge in 51% of human submucous neurons | [45] | ||
Chelidonium majus (root) | human epithelial cell line T84 human enteric neurons | ||||||
Silybum marianum (fruit) | |||||||
Melissa officinalis (leaf) | |||||||
Carum carvi (fruit) | |||||||
Glycyrrhiza glabra (root) | |||||||
Angelica sinensis (root) | In vivo | Wistar rats | - | Single dose | ↑Afferent discharge to 5-HT and bradykinin dose-dependently | [47] | |
Matricaria recutita (flower) | |||||||
Mentha piperita (leaf) | Double-blind, randomized, placebo-controlled, multi-centre trial | IBS patients | - | 4 wk | Significant improvement in IBS symptom scale and abdominal pain scale in STW 5 group compared with placebo | [44] | |
STW 5-II | Iberis amara (whole plant) Melissa officinalis (leaf) Carum carvi (fruit) | Double-blind, randomized, placebo-controlled, multi-centre trial | IBS patients | - | 4 wk | Significant improvement in IBS symptom scale and abdominal pain scale in STW 5-II group compared with placebo | [44] |
Glycyrrhiza glabra (root) | |||||||
Matricaria recutita (flower) | |||||||
Mentha piperita (leaf) | |||||||
Padma Lax | Aloe barbadensis A. ferox (extract) | Randomized, double-blind, placebo-controlled trial | Constipation predominant-IBS patients | - | 3 mo | Significant improvement compared to placebo in constipation, severity of abdominal pain, incomplete evacuation, abdominal distension and flatus/flatulence | [43] |
Jateorhiza palmata (root) | Significantly more Padma Lax patients compared to placebo rated the current treatment superior to previous therapies tried for IBS | ||||||
Marsdenia condurango (bark), Rhamnus frangula (bark) | Laboratory parameters displayed no clinically significant changes | ||||||
Gentiana lutea (root) | |||||||
Inula helenium (rhizome) | |||||||
Terminalia chebula (fruit) | |||||||
Piper longum (fruit) Rhamnus purshiana. (bark) | |||||||
Rheum palmatum (root) | |||||||
Strychnos nux-vomica (seed) | |||||||
Zingiber officinale (root) | |||||||
TXNG | Paeonia lactiflora (root) | Prospective, randomized, double-blind, placebo-controlled trial | Diarrhea predominant-IBS patients | - | 3 wk | ↓IBS-related pain in the TXNG group compared with the placebo | [52] |
Atractylodes macrocephala (rhizome) | ↓Frequency and the duration of abdominal pain between the TXNG group and the placebo | ||||||
Citrus reticulate (green unripe exocarp) | Improvement of IBS-related stool in form or appearance in the TXNG group in comparison with the placebo | ||||||
Allium macrostemon (bulb) | ↓Stool frequency in the TXNG group compared with the placebo | ||||||
Improvement of stool passage (urgency or | |||||||
Feeling of incomplete rectal emptying) in the TXNG group compared with the placebo. | |||||||
Improvement in IBS-related diarrhea in the TXNG group compared to placebo | |||||||
No statistical difference in either the effective time of IBS-related pain or the effective time of IBS-related diarrhea between the two groups | |||||||
↓IBS-related pain alleviation time and the IBS-related diarrhea alleviation time in the TXNG group compared to those in the placebo group | |||||||
TXYF | Atractylodes macrocephala (rhizome) | In vivo | Maternal separation-induced visceral hypersensitivity rats | - | 2 wk | ↓Pain threshold pressure and abdominal withdrawal reflex scores in a dose-dependent manner | [54] |
Paeonia lactiflora (root) | ↓ 5-HT levels in serum | ||||||
Citrus sinensis (dried old peel) | ↓Corticotrophin releasing factor concentrations in the brain | ||||||
Ledebouriella divaricata (root) | Visceral hypersensitivity alleviation was dependent on the substance P expression in the colon mucosa | ||||||
Randomized placebo-controlled trial | Diarrhea predominant-IBS patients | Miyarisan | 4 wk | No significant difference between two groups in terms of the total efficacy or the scores of symptoms before and after treatment | [53] | ||
↓The number of activated mast cells in the intervention | |||||||
TCM | Atractylodes macrocephala (rhizome) | Randomized placebo-controlled trial | Diarrhea predominant-IBS patients | - | 16 wk (8 wk drug administration +8 wk follow up) | No significant difference in the proportion of patients with global symptom improvement between the TCM and placebo groups at week 8 and at week 16 | [51] |
Astragalus membranaceus (root) | No difference in individual symptom scores and the quality-of-life assessment between the two groups at all time points | ||||||
Paeonia lactiflora (peeled root, fried) | |||||||
Atractylodes chinensis (rhizome) | |||||||
Bupleurum chinense (root) | |||||||
Citrus reticulata (peel) | |||||||
Saposhnikovia divaricata (root) | |||||||
Paniculata (twigs) | |||||||
Punica granatum (rind) | |||||||
Portulaca oleracea (above-ground parts) | |||||||
Coptis chinensis (rhizome) |
- Citation: Rahimi R, Abdollahi M. Herbal medicines for the management of irritable bowel syndrome: A comprehensive review. World J Gastroenterol 2012; 18(7): 589-600
- URL: https://www.wjgnet.com/1007-9327/full/v18/i7/589.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i7.589